John R Ingram - Concepedia

Author

John R Ingram

Also Known As

Carsten Flohr, Iltefat H. Hamzavi, Ingram, J.R., Ingram, John, Ingram, John R, Ingram, John R., J INGRAM, J Ingram, J R Ingram, J. Ingram

274

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Cardiff University Zealand University Hospital University Hospital of Wales Penn State Milton S. Hershey Medical Center University of Toronto

About

John R Ingram is an author at Cardiff University specializing in medicine, dermatology, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	811
2	Education	1	1	23
3	Engineering	1	1	51
4	Health Sciences	1	1	18
5	Nursing	1	1	23

John R Ingram

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity Christos C. Zouboulis, Thrasyvoulos Tzellos, Gregor B. E. Jemec, British Journal of Dermatology	2017	430
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project Amit Garg, Erica Neuren, Denny Cha, Journal of the American Academy of Dermatology Health PolicyGlobal SurveyPatient SafetyInternational HealthOutcomes Research	2019	268
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa John R Ingram, Sara Jenkins‐Jones, Duleeka Knipe, British Journal of Dermatology	2017	225
British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018 John R Ingram, Fiona Collier, D. Brown, British Journal of Dermatology British AssociationAllergyDermatologists GuidelinesContact DermatitisClinical Dermatology	2018	173
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process Linnea Thorlacius, John R Ingram, Bente Villumsen, British Journal of Dermatology	2018	165
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials Alexa B. Kimball, Gregor B. E. Jemec, Christopher J. Sayed, The Lancet Moderate-to-severe Hidradenitis SuppurativaBe Heard IiBe HeardClinical DermatologyDermatology	2024	128
Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey Rubina Shah, Faraz M Ali, Stuart J Nixon, BMJ Open	2021	127
The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials Joslyn S. Kirby, Linnea Thorlacius, Bente Villumsen, British Journal of Dermatology	2019	104
A Randomized Trial of Nicotine Enemas for Active Ulcerative Colitis John R Ingram, Gareth Thomas, John Rhodes, Clinical Gastroenterology and Hepatology NicotineGastroenterologyRandomized TrialUlcerative ColitisMedicine	2005	70
Inter‐rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa Linnea Thorlacius, Amit Garg, Peter Theut Riis, British Journal of Dermatology	2019	69

Page 1